Company: SVREW
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001213900-25-028398
Chunk: 12

Company: SaverOne 2014 Ltd.
Filing Date: 2025-04-03
Form: 424B3
Chunk 12
---
 Form F-1 up to 390,857,940 Ordinary Shares represented by 325,797 ADSs issuable upon exercise of the Investor Warrants at an exercise price of $10.664 per ADS. The Investor Warrants may only be exercised on a cashless basis if there is no effective registration statement or a prospectus contained therein that covers the resale of the Ordinary Shares represented by the ADS underlying such Investor Warrants.

In connection with the Registered Offering and the Private Placement Offering, the Company engaged H.C. Wainwright & Co., LLC as its exclusive placement agent (the “Placement Agent”). At the Closing, the Company issued to the designees of the Placement Agent, warrants to purchase up to an aggregate of 11,403 ADSs at an exercise price of $11.66375 per share (the “Placement Agent Warrants”). The Placement Agent Warrants have the same terms as the Investor Warrants, except that they are exercisable for a period of five (5) years following the commencement of the sales in the Registered Direct Offering.

The Investor Warrants, the Placement Agent Warrants and the ADSs issuable upon the exercise of such warrants (collectively, the “Warrant Shares”) were offered by the Company pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act, and Rule 506 of Regulation D promulgated thereunder and have not been registered under the Securities Act or applicable state securities laws.

We are registering in this Registration Statement the Warrant Shares issuable upon exercise of the Investor the Warrants.

In connection with the January 2025 Offering, the Company agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of, any ADS or any securities convertible into or exercisable or exchangeable for ADSs or file any registration statement or prospectus, or any amendment or supplement thereto for 15 days after the January 2025 Offering Closing Date, subject to certain exceptions. In addition, we agreed not to effect or enter into an agreement to effect any issuance of Ordinary Shares represented by ADS or any securities convertible into or exercisable or exchangeable for shares of ADS involving a Variable Rate Transaction (as defined in the January 2025 Purchase Agreement) until 180 days after the Closing of the Private Placement Offering, subject to certain exceptions.

<div align='center'>4</div>

Other Transactions

On July 16, 2024 the Company
entered into a new Standby Equity Purchase Agreement (the